Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): ##STR00001## including stereoisomers, salts and tautomers thereof, R.sup.1, R.sup.2, R.sup.3, L.sup.1, L.sup.2, L.sup.3, L.sup.4, L.sup.5, L.sup.6, M.sup.1, M.sup.2, A, q, w and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.

The present invention provides a compound of formula (II): an inhibitor of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases. Its prodrugs are disclosed. ##STR00001##

Bisphosphite ligands based on benzopinacol with an open outer unit, and the use thereof in hydroformylation.

A phosphorus-containing compound is represented by the formula (I):

##STR00001##

The phosphorus-containing compound has excellent biodegradability and oxidation resistance, and is suitable for promoting biodegradation of lubricating oil product.

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

A flame retardant for thermosetting resin containing an aromatic phosphoric acid ester represented by the general formula (I):

##STR00001##

wherein R.sup.1 to R.sup.4 each independently represent a hydrogen atom, a C.sub.1-4 alkyl group, or a C.sub.1-4 alkoxy group; R.sup.5, R.sup.6, and R.sup.9 each independently represent a C.sub.1-10 alkyl group or a C.sub.1-10alkoxy group; R.sup.7 and R.sup.8 each independently represent a C.sub.1-4 alkyl group or a C.sub.1-4 alkoxy group; n represents an integer of 1 to 10; n.sup.1 and n.sup.2 each independently represent an integer of 0 to 3; m.sup.1 and m.sup.2 each independently represent an integer of 0 to 4; p represents an integer of 0 to 26; and k represents an integer of 1 to 12; and when p is 2 or more, any two substituents R.sup.9 may be bonded to each other, and may be bonded to a carbon atom(s) of a ring to which the above substituents R.sup.9 are bonded, forming another ring.

Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I):

##STR00001## including stereoisomers, salts and tautomers thereof, R.sup.1, R.sup.2, R.sup.3L.sup.1, L.sup.2, L.sup.3, L.sup.4, L.sup.5, L.sup.6, M.sup.1, M.sup.2, A, q, w and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.

The present invention has an object to provide a positive electrode active material for a magnesium battery; and a magnesium battery which has a high operating voltage with respect to magnesium and can be repeatedly charged and discharged at a high capacity retention rate, using the positive electrode active material.

The present invention relates to a positive electrode active material for a magnesium battery, containing a compound represented by the general formula (1), a positive electrode material composition for a magnesium battery, a positive electrode for a magnesium battery, and a magnesium battery:

Ag.sub.pSO.sub.4  (1) [in the formula (1), p satisfies 0<p≤2].

This document relates to functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such functionalized polymers.

The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease.